Classical Immunoproteomics: Serological Proteome Analysis (SERPA) for Antigen Identification
The study of the humoral immune response to infectious and chronic diseases is important for understanding the disease progression, identification of protective antigens, vaccine development, and discovery of biomarkers for early diagnosis. Proteomic approaches, including serological proteome analysis (SERPA), have been used to identify the repertoire of immunoreactive proteins in various diseases. In this chapter, we provide an outline of the SERPA approach, using the analysis of sera from mice vaccinated with a live attenuated tularemia vaccine as an example.
Key wordsSERPA Serological proteome analysis Western blotting Immunoproteomics Comparative immunoproteomics Francisella Tularemia Live vaccine strain Immunoreactivity Antigens Biomarkers
This work was supported by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Contract No. HHSN266200500041C, and in part by the National Research Council, Canada. The authors thank Dr Freyja Lynn, Vicki Pierson, Kristin Debord, and Patrick Sanz (National Institutes of Allergy and Infectious Diseases); Dr J. Wayne Conlan, Luc Tessier, and Marianne Savicky (National Research Council, Canada); and Gretchen Stup (DynPort Vaccine Company) for their contributions throughout this work.
- 18.Dai L, Qu Y, Li J et al (2017) Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer. Oncotarget 8:36664–36673PubMedPubMedCentralGoogle Scholar
- 39.Post DMB, Slütter B, Schilling B et al (2017) Characterization of inner and outer membrane proteins from Francisella tularensis strains LVS and Schu S4 and identification of potential subunit vaccine candidates. MBio 8. https://doi.org/10.1128/mBio.01592-17